Dr. Rhett Daugherty, MD
7704 Matapeake Business DR Ste 310, Brandywine, MD 20613 • +1-537-555-6333
Medical Education: Accredited U.S. Medical School (Class of 2009)
What This Doctor Actually Performs: CMS Medicare Utilization & Brandywine Percentiles
NPI #1679544365 • CBSA Regional • Urology
Operating out of Brandywine, MD (7704 Matapeake Business DR Ste 310), Urology clinician Dr. Rhett Daugherty, MD (accredited MD/DO training, 2009) maintains a focused low-volume boutique caseload (0th Brandywine percentile) (64.34th MD percentile; Z-score -0.00σ across 10,006 documented services) with sub-specialty concentration in 86 Active CMS HCPCS Codes.
Granular CPT/HCPCS billing distribution at 7704 Matapeake Business DR Ste 310 shows Dr. Rhett Daugherty's primary concentration in Established Urologic, BPH & Androgen Evaluation (code 99214: 2571x/yr, 12th local percentile) alongside Ultrasound Measurement of Post-Void Residual Urine Capacity (51798: 1928x/yr, $34–$49).
Uninsured and high-deductible cash patients visiting Dr. Rhett Daugherty in Brandywine (20613) face an estimated $209.00 initial evaluation fee at 7704 Matapeake Business DR Ste 310 (hybrid in-clinic and telehealth video consults; 21-minute average reception wait; bedside manner 4.74/5 from 11 verified reports).
Credentialed as an MD specialist with 17 years post-graduation experience since completing medical school at an LCME/COCA institution (2009), Dr. Daugherty coordinates 86 Active CMS HCPCS Codes workups from 7704 Matapeake Business DR Ste 310 (+1-537-555-6333).
Compared against Brandywine, MD Urology peers
10,006 annual services across 937 beneficiaries
Standard deviations from MD Urology mean utilization
Top Billed HCPCS/CPT Procedures & GPCI Self-Pay Cash Benchmarks
| HCPCS | Clinical Procedure Description | Annual Volume | Local Pct | Est. Cash Range |
|---|---|---|---|---|
| 99214 | Established Urologic, BPH & Androgen Evaluation | 2,571 | 12th | $82 – $113 |
| 51798 | Ultrasound Measurement of Post-Void Residual Urine Capacity | 1,928 | 12th | $34 – $49 |
| 52000 | Diagnostic Cystourethroscopy Lower Urinary Tract Inspection | 1,214 | 12th | $169 – $231 |
| 51741 | Complex Electronic Uroflowmetry Stream Calibration | 857 | 12th | $47 – $64 |
| 99204 | New Patient Urologic & Prostate Diagnostic Consultation | 571 | 12th | $116 – $159 |
| 96372 | Therapeutic Subcutaneous/Intramuscular Injection Administration (86 HCPCS billing breadth) | 2,865 | 0th | $74 – $107 |
Are you Dr. Rhett Daugherty? Embed your Official DotMD Verification Badge (0-JS SVG)
Paste this lightweight SVG snippet onto your clinic bio page in Brandywine, MD:
<a href="https://dotmd.com/doctors/rhett-daugherty-md-brandywine-md-1679544365" title="Dr. Rhett Daugherty, MD - Verified CMS Utilization on DotMD"><img src="https://dotmd.com/badges/npi/1679544365.svg" alt="Dr. Rhett Daugherty Urology Badge" width="280" height="72" /></a>
Dr. Rhett Daugherty, MD Fair Cash-Pay & Waiting-Room Scorecard
| Metric | Verified Benchmark | Source |
|---|---|---|
| Dr. Daugherty National Provider Identifier | NPI #1679544365 (MD) | CMS NPPES Registry (20613) |
| Dr. Daugherty Brandywine CMS Volume Rank | 0.00th Pct (10,006 CMS svcs; Z -0.002σ) | CMS Medicare Part B (MD Urology) |
| Fair Cash-Pay New-Patient Benchmark | $209.00 (CPT 99204 GPCI Benchmark) | CMS Geographic Practice Cost Index (Brandywine, MD) |
| Waiting-Room Wait Time & Cash Friendliness | $209.00 avg paid • 21 min lobby wait | 11 Anonymous Patient Reports |
| Listens Without Rushing & Modern Protocol Score | 4.74/5 Listening • 4.50/5 Modern Labs | CMS Provider Practice Cohort |
“Waiting Room” Patient Reality Scorecard
Ask our AI Specialists anything about Dr. Rhett Daugherty
Other High-Volume Urology Specialists in Brandywine, MD
Ranked strictly by CMS Medicare volumeDr. Daugherty Waiting-Room Q&A & Patient Experience Logs
Anonymous patient-submitted wait times, cash visit fees, and bedside manner discussions in Brandywine, MD.
Share your self-pay visit cost and lobby wait time—no account, email, or IP stored.
Filter Dr. Rhett Daugherty community threads and patient logs by age, biological sex, dosage, and treatment duration.